Yi Lisa Hwa

14PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical infection agents (incl. prions)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 25, 2026
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

|Aug 03, 2026
High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients.

|Oct 04, 2025
Clinical Characteristics, Treatment Responses and Outcomes of Light Chain Multiple Myeloma.

Abiola Bolarinwa, Saurabh Zanwar, Nadine Abdallah

|Jan 02, 2023
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.

Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor

|Oct 13, 2022
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.

Matthew Ho, Saurabh Zanwar, Francis K Buadi

|Jan 11, 2022
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.

Nadine H Abdallah, Thomas Habermann, Francis K Buadi

Pageof 3

Frequent Collaborators

13 joint publications

Angela Dispenzieri

12 joint publications

Morie A Gertz

12 joint publications

Nelson R Leung

12 joint publications

Wilson I Gonsalves